IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that affect all members, whether they utilize weight loss drugs or not, IBX said in a statement
Available online at: March 17, 2025)
Within three days, the company saw its share price plunge 27% after delivering disappointing 2026 guidance, only to be blindsided a day later by telehealth platform HIMS launching a $49 Wegovy pill copy. For a brief moment, it looked as if regulatory arbitrage might permanently erode one of the most valuable moats in global pharma
1.) Discussion Our study demonstrates that arGLP-1 are a highly effective and well-tolerated option for managing IWL, WR, and improvement of comorbidities following bariatric surgery